Ortho Biotech modifies prescribing information for Procrit following guidance from FDA March 12, 2008
ProMetic reports results from phase II trial of PBI-1402 in chemotherapy-induced anemia March 10, 2008
FDA agrees with remaining two protocols for Alizyme's phase III clinical studies of cetilistat March 7, 2008
DiaMedica receives E.U. regulatory clearance for phase II study of DM-99 in type 2 diabetes March 7, 2008
RSS